Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vor Biopharma Inc. - Common Stock (NQ:VOR)

17.09 +2.39 (+16.26%)
Streaming Delayed Price Updated: 1:57 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,764,797
Open 14.88
Bid (Size) 17.03 (600)
Ask (Size) 17.15 (700)
Prev. Close 14.70
Today's Range 14.86 - 17.60
52wk Range 2.622 - 65.80
Shares Outstanding 66,956,800
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
First and only dual BAFF/APRIL inhibitor in primary Sjögren’s disease, one of the largest autoimmune diseases without an approved therapy 
From Vor Biopharma
Via GlobeNewswire

Performance

YTD
+46.8%
+46.8%
1 Month
+7.5%
+7.5%
3 Month
+24.6%
+24.6%
6 Month
-57.2%
-57.2%
1 Year
+19.1%
+19.1%

More News

Read More
News headline image
What's Behind The Jump In Vor Biopharma Stock? ↗
Via Benzinga
News headline image
Vor Bio Announces $75 Million Private Placement with TCGX
From Vor Biopharma
Via GlobeNewswire
VOR Shares Rally Over 40%In Pre-Market Trade After JPMorgan Initiates Bullish Coverage ↗
Via Stocktwits
News headline image
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Announces $150 Million Private Placement
From Vor Biopharma
Via GlobeNewswire
News headline image
What's going on in today's session ↗
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch ↗
Via Stocktwits
Topics ETFs Economy Government
News headline image
Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From Vor Biopharma
Via GlobeNewswire
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial ↗
Via Benzinga
News headline image
US Stocks Mixed; Sea Shares Gain After Q3 Results ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
From Vor Biopharma
Via GlobeNewswire

Frequently Asked Questions

Is Vor Biopharma Inc. - Common Stock publicly traded?
Yes, Vor Biopharma Inc. - Common Stock is publicly traded.
What exchange does Vor Biopharma Inc. - Common Stock trade on?
Vor Biopharma Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vor Biopharma Inc. - Common Stock?
The ticker symbol for Vor Biopharma Inc. - Common Stock is VOR on the Nasdaq Stock Market
What is the current price of Vor Biopharma Inc. - Common Stock?
The current price of Vor Biopharma Inc. - Common Stock is 17.09
When was Vor Biopharma Inc. - Common Stock last traded?
The last trade of Vor Biopharma Inc. - Common Stock was at 03/31/26 01:57 PM ET
What is the market capitalization of Vor Biopharma Inc. - Common Stock?
The market capitalization of Vor Biopharma Inc. - Common Stock is 1.14B
How many shares of Vor Biopharma Inc. - Common Stock are outstanding?
Vor Biopharma Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS